Biosimulation Market
Surge in penetration of software in healthcare to augment the demand of biosimulation: Opportunities ahead
Biosimulation Market by Product Type, Deployment Mode, End Use & Region - Forecast 2022 - 2032
Biosimulation Market Outlook (2022-2032)
The Global Biosimulation Market was valued at around US$ 2.6 Bn in 2021, with a projected CAGR 21.5% for the next ten years; the market is likely to reach a valuation of US$ 20.9 Bn by the end of 2032. The need for developing new drugs to compact the developing diseases will drive the demand for biosimulation.
|
Report Attributes |
Details |
|
Estimated Market Value (2022E) |
US$ 3.1 Bn |
|
Forecasted Market Value (2032F) |
US$ 20.9 Bn |
|
Global Market Growth Rate (2022-2032) |
21.5% CAGR |
|
United States Growth Rate (2022-2032) |
~21.6% CAGR |
|
Key Companies Covered |
|
Future Market Insight’s analysis reveals that the most of the revenue is generated from biosimulation software. On the other hand, drug development in deployment mode will be the most lucrative with a CAGR 22.8% during the forecast period.
Let us know your requirement to get
100% FREE customization
Sale Analysis of Biosimulation from 2015 to 2021 Vs Market Outlook For 2022 to 2032
The global market for Biosimulation registered a CAGR of 15.8% during 2015-2021. The market growth is projected to surge due to technological advancement in software for biosimulation. In 2021, the global market size of biosimulation was valued at US$ 2.6 Bn and is estimated to increase to a valuation of US$ 3.1 Bn in 2022.
Biosimulation is the use of computer-aided mathematical models to simulate biological processes. Biosimulation has various applications like developing new drugs and discovering new drugs. The drug discovery and development process is expensive, and the failure of a therapeutic molecule in the late stages of drug development results in a massive waste of time, money, and other resources. As a result, a predictive tool is required to aid in predicting the future results of drug development through simulation of the biological processes involved.
Biosimulation helps to simulate the effect of drugs on the body with the help of simulation. Pharmaceutical manufacturers are using biosimulation throughout the drug development process to identify the positive and negative effects of their drug can have on the people if the drug is used.
The global biosimulation market has predicted to surge ahead at a CAGR of 21.5% and record sales worth US$ 20.9 Bn by the end of 2032. US will continue to be the largest procurer of biosimulation throughout the analysis period accounting for over US$ 7.5 Bn absolute dollar opportunity in the coming 10-year epoch.
How will the Reduction in Operating Costs of Pharmaceutical Companies through Biosimulation Stimulate Market Growth?
Rising global healthcare spending will increase spending on developing drugs, which will drive revenue for biosimulation. Many drugs for mimic diseases are developed using biosimulation. Computers operating sickness simulations with the aid of biosimulation software can be used to conduct virtual clinical trials for new pharmaceutical treatments. Developing a new drug requires significant research and studies. Every stage of drug development from clinical trials to the approval of the drug has a serious chance of failure. Biosimulation lowers these odds by predicting these failures in the development process. Also, it lowers the cost of pharmaceutical companies by lowering the number of clinical trials.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhat factors are Restraining the Biosimulation Market?
Biosimulation uses mathematical equations to depict a real-life process that occurs within the human body. Researchers may simulate a wide range of scenarios and examine the behavior of a human system in diverse settings since it can duplicate human biological elements and their interactions with medications when they are put into the system.
In order to obtain a better result, skilled expertise is required to perform the biosimulation software. The demand for skilled expertise is high in research laboratories and companies. In addition, this process is very complex and highly technical as they involve various laboratory documentation systems. In order to overcome this issue, researchers must receive proper training and assistance. These factors make biosimulation development time-consuming, thus limiting its adoption among researchers.
Regional -Wise Insights
How is the demand for Biosimulation shaping up in North America?
North America holds the largest market for biosimulation. The rising chronic disease among the population in the region and regulations implemented by the governments for patient safety and treatment standards is driving the demand for biosimulation in the region. In silico modeling is being used to boost the standard of patient care and safety. This is particularly true for the implementation of regulatory laws that have high standards for the safety and care of patients.
A unified Market Research Subscription Platform, built for today's disparate research needs.
Country-Wise Insights
US Biosimulation Market Analysis
The encouraging government policies in the US and the rising healthcare expenditure due to the dominance of chronic diseases are key factors that are rising drug development and discovery in the US. The market for biosimulation in the US has projected to reach a valuation of US$ 8.7 Bn in 2032.
China Biosimulation Market Analysis
The government policies for developing quality pharmaceutical drugs and the Chinese government‘s commitment to develop and increase innovation in its healthcare system is driving the market for biosimulation in China. Chinese government’s plan to be a global leader in drug development is attracting drug development and pharmaceutical companies to China for the development of new drugs, which will further increase the demand for the biosimulation market over the years. The market for biosimulation in China is forecasted to reach a valuation of US$ 1.7 Bn by 2032.
U.K. Biosimulation Market Analysis
The market in the U.K. is projected to reach a valuation of US$ 880 Mn by 2032. The market is expected to grow at a CAGR of 20.6% during 2022 – 2032 to gross an absolute dollar opportunity of US$ 336 Mn.
Japan Biosimulation Market Analysis
The market for biosimulation in Japan is expected to reach US$ 1.2 Bn by 2032. Growing at a CAGR of 25.1% during the forecast period, the market is likely to garner an absolute dollar opportunity of US$ 1.1 Bn.
Category-Wise Insights
How is Biosimulation revenue through CROs going to perform over the forecast years?
The market through the CROs segment is anticipated to grow at the fastest rate during the forecast period. The growing tendency of firms to cut total spending is expected to drive segment growth. Other factors like increased efficiency and the ability to focus on core areas for company development will also drive the use of biosimulation in CROs.
Competitive Landscape
The key companies operating in the biosimulation market include Certara, Dassault Systemes, Advanced Chemistry Development, Simulation Plus Inc., Schrodinger, Inc., Chemical Computing Group, Physiomics Plc, Rosa & Co. LLC, BioSimulation Consulting Inc., Genedata AG, Instem Group of Companies, PPD, Inc., Insilico Biotechnology AG, Rhenovia Pharma, LeadInvent Technologies, Nuventra Pharma, and In Silico Biosciences.
Some of the recent developments by key providers of biosimulation are as follows:
- In June 2022, Certara announced its new version of Biosimulation software for the progress of Novel Biologics. The new version includes Immunogenicity (IG), Immuno-Oncology (IO), and Vaccine simulators to understand and predict how drugs work and point out the key questions in the development of novel biologic therapies.
- In June 2022, Genedata AG announced that Syros Pharmaceuticals has chosen Genedata AG’s Genedata Profiler as its data integration and investigative platform to accelerate its translational research strategy.
- In March 2022, Advanced Chemistry labs announced that Pharmaron Inc. has chosen its NMR processing and interpretation software.
- In March 2022, Simulation Plus, Inc. released its Membrane Plus 3.0 software. The new software includes improved data handling and simulation performance for in vitro-in vivo for extrapolation (IVIVE) for permeability, skin penetration and release assay systems.
- In February 2022, the US Food and Drug Administration (FDA) approved the license for Certara’s Immunogenicity (IG) stimulator to research and assess immunogenicity in protein-based remedies.
- In February 2022, Physiomics Plc updated a new agreement with ValiRx plc. According to the new agreement, ValiRx will be able to use Physiomics Plc’s latest version of its Virtual Tumour technology. Physiomics Plc will also help ValiRx in modeling the use of VAL201 peptide in endometriosis (VAL301) and Coronavirus (BC201).
- In December 2021, Certara announced the release of Pinnacle 21 enterprise 5.1.0, which advances the software for making Clinical trial data for biosimulation and regulatory submission.
- In September 2021, Instem Group of Companies acquired PDS Life Sciences (PDS). This acquisition will help Instem Group of Companies increase their research and development process and enable them to quickly develop and deliver solutions to their clients.
- In March 2021, Instem Group of Companies acquired d-wise a clinical trial and technology and consulting company. Through this acquisition, Instem Group of Companies plans to bring their products faster to the market. The consolidation will also accelerate their research and development process in Insilico modeling and prediction solutions.
Similarly, the team at Future Market Insights has tracked recent developments related to companies offering Biosimulation, which is available in the full report.
Key Segments Covered in Biosimulation Industry Survey
Biosimulation Market by Product Type:
- Services
- In-house services
- Contract services
- Software
Biosimulation Market by Deployment Mode:
- Drug Development
- Drug Discovery
- Other Applications
Biosimulation Market by End-use:
- Pharmaceutical &Biotechnology Companies
- CROs
- Regulatory Authorities
- Academic Research Instituitons
Biosimulation Market by Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East and Africa
Frequently Asked Questions
The global biosimulation market was valued at US$ 2.6 Bn in 2021.
The biosimulation industry is set to witness a high growth rate of 21.5% over the forecasted period and be valued at US$ 20.9 Bn by 2032.
The Biosimulation Market expanded at a CAGR of 15.8% from 2015 through 2021.
Certara, Dassault Systemes, Advanced Chemistry Development, Simulation Plus Inc, and Schrodinger, Inc. are the key providers of biosimulation.
US, UK, China Japan and South Korea are expected to drive the most sales growth of Biosimulation.
The market in the US has forecasted to account for over 40% of the global market share in 2032.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Investment Feasibility Matrix
3.4. Regulatory Landscape
3.4.1. By Key Regions
3.4.2. By Key Countries
4. Global Market Analysis 2015-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2015-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Product Type, 2015-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product Type, 2022-2032
5.3.1. Software
5.3.2. Services
5.3.2.1. In-house Services
5.3.2.2. Contract Services
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2015-2021
5.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032
6. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Deployment Mode
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By Deployment Mode, 2015-2021
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Deployment Mode, 2022-2032
6.3.1. Drug Development
6.3.2. Drug Discovery
6.3.3. Other Applications
6.4. Y-o-Y Growth Trend Analysis By Deployment Mode, 2015-2021
6.5. Absolute $ Opportunity Analysis By Deployment Mode, 2022-2032
7. Global Market Analysis 2015-2021 and Forecast 2022-2032, By End Use
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Mn) Analysis By End Use, 2015-2021
7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End Use, 2022-2032
7.3.1. Pharmaceutical & Biotechnology Companies
7.3.2. CROs
7.3.3. Regulatory Authorities
7.3.4. Academic Research Institutions
7.4. Y-o-Y Growth Trend Analysis By End Use, 2015-2021
7.5. Absolute $ Opportunity Analysis By End Use, 2022-2032
8. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2015-2021
8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. East Asia
8.3.5. South Asia
8.3.6. Oceania
8.3.7. MEA
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2015-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. U.S.
9.2.1.2. Canada
9.2.2. By Product Type
9.2.3. By Deployment Mode
9.2.4. By End Use
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By Deployment Mode
9.3.4. By End Use
9.4. Key Takeaways
10. Latin America Market Analysis 2015-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Argentina
10.2.1.4. Rest of Latin America
10.2.2. By Product Type
10.2.3. By Deployment Mode
10.2.4. By End Use
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By Deployment Mode
10.3.4. By End Use
10.4. Key Takeaways
11. Europe Market Analysis 2015-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. Italy
11.2.1.3. France
11.2.1.4. U.K.
11.2.1.5. Spain
11.2.1.6. Russia
11.2.1.7. BENELUX
11.2.1.8. Rest of Europe
11.2.2. By Product Type
11.2.3. By Deployment Mode
11.2.4. By End Use
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By Deployment Mode
11.3.4. By End Use
11.4. Key Takeaways
12. East Asia Market Analysis 2015-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.2. By Product Type
12.2.3. By Deployment Mode
12.2.4. By End Use
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By Deployment Mode
12.3.4. By End Use
12.4. Key Takeaways
13. South Asia Market Analysis 2015-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Thailand
13.2.1.3. Malaysia
13.2.1.4. Indonesia
13.2.1.5. Rest of South Asia
13.2.2. By Product Type
13.2.3. By Deployment Mode
13.2.4. By End Use
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Type
13.3.3. By Deployment Mode
13.3.4. By End Use
13.4. Key Takeaways
14. Oceania Market Analysis 2015-2021 and Forecast 2022-2032, By Country
14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
14.2.1. By Country
14.2.1.1. Australia
14.2.1.2. New Zealand
14.2.2. By Product Type
14.2.3. By Deployment Mode
14.2.4. By End Use
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product Type
14.3.3. By Deployment Mode
14.3.4. By End Use
14.4. Key Takeaways
15. MEA Market Analysis 2015-2021 and Forecast 2022-2032, By Country
15.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
15.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
15.2.1. By Country
15.2.1.1. GCC
15.2.1.2. Rest of MEA
15.2.2. By Product Type
15.2.3. By Deployment Mode
15.2.4. By End Use
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product Type
15.3.3. By Deployment Mode
15.3.4. By End Use
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. U.S.
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2021
16.1.2.1. By Product Type
16.1.2.2. By Deployment Mode
16.1.2.3. By End Use
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2021
16.2.2.1. By Product Type
16.2.2.2. By Deployment Mode
16.2.2.3. By End Use
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2021
16.3.2.1. By Product Type
16.3.2.2. By Deployment Mode
16.3.2.3. By End Use
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2021
16.4.2.1. By Product Type
16.4.2.2. By Deployment Mode
16.4.2.3. By End Use
16.5. Argentina
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2021
16.5.2.1. By Product Type
16.5.2.2. By Deployment Mode
16.5.2.3. By End Use
16.6. Germany
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2021
16.6.2.1. By Product Type
16.6.2.2. By Deployment Mode
16.6.2.3. By End Use
16.7. Italy
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2021
16.7.2.1. By Product Type
16.7.2.2. By Deployment Mode
16.7.2.3. By End Use
16.8. France
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2021
16.8.2.1. By Product Type
16.8.2.2. By Deployment Mode
16.8.2.3. By End Use
16.9. U.K.
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2021
16.9.2.1. By Product Type
16.9.2.2. By Deployment Mode
16.9.2.3. By End Use
16.10. Spain
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2021
16.10.2.1. By Product Type
16.10.2.2. By Deployment Mode
16.10.2.3. By End Use
16.11. Russia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2021
16.11.2.1. By Product Type
16.11.2.2. By Deployment Mode
16.11.2.3. By End Use
16.12. BENELUX
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2021
16.12.2.1. By Product Type
16.12.2.2. By Deployment Mode
16.12.2.3. By End Use
16.13. China
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2021
16.13.2.1. By Product Type
16.13.2.2. By Deployment Mode
16.13.2.3. By End Use
16.14. Japan
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2021
16.14.2.1. By Product Type
16.14.2.2. By Deployment Mode
16.14.2.3. By End Use
16.15. South Korea
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2021
16.15.2.1. By Product Type
16.15.2.2. By Deployment Mode
16.15.2.3. By End Use
16.16. India
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2021
16.16.2.1. By Product Type
16.16.2.2. By Deployment Mode
16.16.2.3. By End Use
16.17. Thailand
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2021
16.17.2.1. By Product Type
16.17.2.2. By Deployment Mode
16.17.2.3. By End Use
16.18. Malaysia
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2021
16.18.2.1. By Product Type
16.18.2.2. By Deployment Mode
16.18.2.3. By End Use
16.19. Indonesia
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2021
16.19.2.1. By Product Type
16.19.2.2. By Deployment Mode
16.19.2.3. By End Use
16.20. Australia
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2021
16.20.2.1. By Product Type
16.20.2.2. By Deployment Mode
16.20.2.3. By End Use
16.21. New Zealand
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2021
16.21.2.1. By Product Type
16.21.2.2. By Deployment Mode
16.21.2.3. By End Use
16.22. GCC Countries
16.22.1. Pricing Analysis
16.22.2. Market Share Analysis, 2021
16.22.2.1. By Product Type
16.22.2.2. By Deployment Mode
16.22.2.3. By End Use
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Product Type
17.3.3. By Deployment Mode
17.3.4. By End Use
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Certara
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.1.5.2. Product Strategy
18.1.1.5.3. Channel Strategy
18.1.2. Dassault Systemes
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.2.5.2. Product Strategy
18.1.2.5.3. Channel Strategy
18.1.3. Advanced Chemistry Development
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.3.5.2. Product Strategy
18.1.3.5.3. Channel Strategy
18.1.4. Simulation Plus Inc
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.4.5.2. Product Strategy
18.1.4.5.3. Channel Strategy
18.1.5. Schrodinger, Inc.
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.5.5.2. Product Strategy
18.1.5.5.3. Channel Strategy
18.1.6. Chemical Computing Group
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.6.5.2. Product Strategy
18.1.6.5.3. Channel Strategy
18.1.7. Physiomics Plc
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.7.5.2. Product Strategy
18.1.7.5.3. Channel Strategy
18.1.8. Rosa & Co. LLC
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.8.5.2. Product Strategy
18.1.8.5.3. Channel Strategy
18.1.9. Consulting Inc.
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.9.5.2. Product Strategy
18.1.9.5.3. Channel Strategy
18.1.10. Genedata AG
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
18.1.10.5.2. Product Strategy
18.1.10.5.3. Channel Strategy
18.1.11. Instem Group of Companies
18.1.11.1. Overview
18.1.11.2. Product Portfolio
18.1.11.3. Profitability by Market Segments
18.1.11.4. Sales Footprint
18.1.11.5. Strategy Overview
18.1.11.5.1. Marketing Strategy
18.1.11.5.2. Product Strategy
18.1.11.5.3. Channel Strategy
18.1.12. PPD, Inc.
18.1.12.1. Overview
18.1.12.2. Product Portfolio
18.1.12.3. Profitability by Market Segments
18.1.12.4. Sales Footprint
18.1.12.5. Strategy Overview
18.1.12.5.1. Marketing Strategy
18.1.12.5.2. Product Strategy
18.1.12.5.3. Channel Strategy
18.1.13. Insilico Biotechnology AG
18.1.13.1. Overview
18.1.13.2. Product Portfolio
18.1.13.3. Profitability by Market Segments
18.1.13.4. Sales Footprint
18.1.13.5. Strategy Overview
18.1.13.5.1. Marketing Strategy
18.1.13.5.2. Product Strategy
18.1.13.5.3. Channel Strategy
18.1.14. Rhenovia Pharma
18.1.14.1. Overview
18.1.14.2. Product Portfolio
18.1.14.3. Profitability by Market Segments
18.1.14.4. Sales Footprint
18.1.14.5. Strategy Overview
18.1.14.5.1. Marketing Strategy
18.1.14.5.2. Product Strategy
18.1.14.5.3. Channel Strategy
18.1.15. LeadInvent Technologies
18.1.15.1. Overview
18.1.15.2. Product Portfolio
18.1.15.3. Profitability by Market Segments
18.1.15.4. Sales Footprint
18.1.15.5. Strategy Overview
18.1.15.5.1. Marketing Strategy
18.1.15.5.2. Product Strategy
18.1.15.5.3. Channel Strategy
18.1.16. Nuventra Pharma
18.1.16.1. Overview
18.1.16.2. Product Portfolio
18.1.16.3. Profitability by Market Segments
18.1.16.4. Sales Footprint
18.1.16.5. Strategy Overview
18.1.16.5.1. Marketing Strategy
18.1.16.5.2. Product Strategy
18.1.16.5.3. Channel Strategy
18.1.17. In Silico Biosciences
18.1.17.1. Overview
18.1.17.2. Product Portfolio
18.1.17.3. Profitability by Market Segments
18.1.17.4. Sales Footprint
18.1.17.5. Strategy Overview
18.1.17.5.1. Marketing Strategy
18.1.17.5.2. Product Strategy
18.1.17.5.3. Channel Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 1: Global Market Value (US$ Mn) Forecast by Region, 2015-2032
Table 2: Global Market Value (US$ Mn) Forecast by Product Type, 2015-2032
Table 3: Global Market Value (US$ Mn) Forecast by Deployment Mode, 2015-2032
Table 4: Global Market Value (US$ Mn) Forecast by End Use, 2015-2032
Table 5: North America Market Value (US$ Mn) Forecast by Country, 2015-2032
Table 6: North America Market Value (US$ Mn) Forecast by Product Type, 2015-2032
Table 7: North America Market Value (US$ Mn) Forecast by Deployment Mode, 2015-2032
Table 8: North America Market Value (US$ Mn) Forecast by End Use, 2015-2032
Table 9: Latin America Market Value (US$ Mn) Forecast by Country, 2015-2032
Table 10: Latin America Market Value (US$ Mn) Forecast by Product Type, 2015-2032
Table 11: Latin America Market Value (US$ Mn) Forecast by Deployment Mode, 2015-2032
Table 12: Latin America Market Value (US$ Mn) Forecast by End Use, 2015-2032
Table 13: Europe Market Value (US$ Mn) Forecast by Country, 2015-2032
Table 14: Europe Market Value (US$ Mn) Forecast by Product Type, 2015-2032
Table 15: Europe Market Value (US$ Mn) Forecast by Deployment Mode, 2015-2032
Table 16: Europe Market Value (US$ Mn) Forecast by End Use, 2015-2032
Table 17: East Asia Market Value (US$ Mn) Forecast by Country, 2015-2032
Table 18: East Asia Market Value (US$ Mn) Forecast by Product Type, 2015-2032
Table 19: East Asia Market Value (US$ Mn) Forecast by Deployment Mode, 2015-2032
Table 20: East Asia Market Value (US$ Mn) Forecast by End Use, 2015-2032
Table 21: South Asia Market Value (US$ Mn) Forecast by Country, 2015-2032
Table 22: South Asia Market Value (US$ Mn) Forecast by Product Type, 2015-2032
Table 23: South Asia Market Value (US$ Mn) Forecast by Deployment Mode, 2015-2032
Table 24: South Asia Market Value (US$ Mn) Forecast by End Use, 2015-2032
Table 25: Oceania Market Value (US$ Mn) Forecast by Country, 2015-2032
Table 26: Oceania Market Value (US$ Mn) Forecast by Product Type, 2015-2032
Table 27: Oceania Market Value (US$ Mn) Forecast by Deployment Mode, 2015-2032
Table 28: Oceania Market Value (US$ Mn) Forecast by End Use, 2015-2032
Table 29: MEA Market Value (US$ Mn) Forecast by Country, 2015-2032
Table 30: MEA Market Value (US$ Mn) Forecast by Product Type, 2015-2032
Table 31: MEA Market Value (US$ Mn) Forecast by Deployment Mode, 2015-2032
Table 32: MEA Market Value (US$ Mn) Forecast by End Use, 2015-2032
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 1: Global Market Value (US$ Mn) by Product Type, 2022-2032
Figure 2: Global Market Value (US$ Mn) by Deployment Mode, 2022-2032
Figure 3: Global Market Value (US$ Mn) by End Use, 2022-2032
Figure 4: Global Market Value (US$ Mn) by Region, 2022-2032
Figure 5: Global Market Value (US$ Mn) Analysis by Region, 2015-2032
Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2022-2032
Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2022-2032
Figure 8: Global Market Value (US$ Mn) Analysis by Product Type, 2015-2032
Figure 9: Global Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 10: Global Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 11: Global Market Value (US$ Mn) Analysis by Deployment Mode, 2015-2032
Figure 12: Global Market Value Share (%) and BPS Analysis by Deployment Mode, 2022-2032
Figure 13: Global Market Y-o-Y Growth (%) Projections by Deployment Mode, 2022-2032
Figure 14: Global Market Value (US$ Mn) Analysis by End Use, 2015-2032
Figure 15: Global Market Value Share (%) and BPS Analysis by End Use, 2022-2032
Figure 16: Global Market Y-o-Y Growth (%) Projections by End Use, 2022-2032
Figure 17: Global Market Attractiveness by Product Type, 2022-2032
Figure 18: Global Market Attractiveness by Deployment Mode, 2022-2032
Figure 19: Global Market Attractiveness by End Use, 2022-2032
Figure 20: Global Market Attractiveness by Region, 2022-2032
Figure 21: North America Market Value (US$ Mn) by Product Type, 2022-2032
Figure 22: North America Market Value (US$ Mn) by Deployment Mode, 2022-2032
Figure 23: North America Market Value (US$ Mn) by End Use, 2022-2032
Figure 24: North America Market Value (US$ Mn) by Country, 2022-2032
Figure 25: North America Market Value (US$ Mn) Analysis by Country, 2015-2032
Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 28: North America Market Value (US$ Mn) Analysis by Product Type, 2015-2032
Figure 29: North America Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 30: North America Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 31: North America Market Value (US$ Mn) Analysis by Deployment Mode, 2015-2032
Figure 32: North America Market Value Share (%) and BPS Analysis by Deployment Mode, 2022-2032
Figure 33: North America Market Y-o-Y Growth (%) Projections by Deployment Mode, 2022-2032
Figure 34: North America Market Value (US$ Mn) Analysis by End Use, 2015-2032
Figure 35: North America Market Value Share (%) and BPS Analysis by End Use, 2022-2032
Figure 36: North America Market Y-o-Y Growth (%) Projections by End Use, 2022-2032
Figure 37: North America Market Attractiveness by Product Type, 2022-2032
Figure 38: North America Market Attractiveness by Deployment Mode, 2022-2032
Figure 39: North America Market Attractiveness by End Use, 2022-2032
Figure 40: North America Market Attractiveness by Country, 2022-2032
Figure 41: Latin America Market Value (US$ Mn) by Product Type, 2022-2032
Figure 42: Latin America Market Value (US$ Mn) by Deployment Mode, 2022-2032
Figure 43: Latin America Market Value (US$ Mn) by End Use, 2022-2032
Figure 44: Latin America Market Value (US$ Mn) by Country, 2022-2032
Figure 45: Latin America Market Value (US$ Mn) Analysis by Country, 2015-2032
Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 48: Latin America Market Value (US$ Mn) Analysis by Product Type, 2015-2032
Figure 49: Latin America Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 51: Latin America Market Value (US$ Mn) Analysis by Deployment Mode, 2015-2032
Figure 52: Latin America Market Value Share (%) and BPS Analysis by Deployment Mode, 2022-2032
Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Deployment Mode, 2022-2032
Figure 54: Latin America Market Value (US$ Mn) Analysis by End Use, 2015-2032
Figure 55: Latin America Market Value Share (%) and BPS Analysis by End Use, 2022-2032
Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End Use, 2022-2032
Figure 57: Latin America Market Attractiveness by Product Type, 2022-2032
Figure 58: Latin America Market Attractiveness by Deployment Mode, 2022-2032
Figure 59: Latin America Market Attractiveness by End Use, 2022-2032
Figure 60: Latin America Market Attractiveness by Country, 2022-2032
Figure 61: Europe Market Value (US$ Mn) by Product Type, 2022-2032
Figure 62: Europe Market Value (US$ Mn) by Deployment Mode, 2022-2032
Figure 63: Europe Market Value (US$ Mn) by End Use, 2022-2032
Figure 64: Europe Market Value (US$ Mn) by Country, 2022-2032
Figure 65: Europe Market Value (US$ Mn) Analysis by Country, 2015-2032
Figure 66: Europe Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 67: Europe Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 68: Europe Market Value (US$ Mn) Analysis by Product Type, 2015-2032
Figure 69: Europe Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 70: Europe Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 71: Europe Market Value (US$ Mn) Analysis by Deployment Mode, 2015-2032
Figure 72: Europe Market Value Share (%) and BPS Analysis by Deployment Mode, 2022-2032
Figure 73: Europe Market Y-o-Y Growth (%) Projections by Deployment Mode, 2022-2032
Figure 74: Europe Market Value (US$ Mn) Analysis by End Use, 2015-2032
Figure 75: Europe Market Value Share (%) and BPS Analysis by End Use, 2022-2032
Figure 76: Europe Market Y-o-Y Growth (%) Projections by End Use, 2022-2032
Figure 77: Europe Market Attractiveness by Product Type, 2022-2032
Figure 78: Europe Market Attractiveness by Deployment Mode, 2022-2032
Figure 79: Europe Market Attractiveness by End Use, 2022-2032
Figure 80: Europe Market Attractiveness by Country, 2022-2032
Figure 81: East Asia Market Value (US$ Mn) by Product Type, 2022-2032
Figure 82: East Asia Market Value (US$ Mn) by Deployment Mode, 2022-2032
Figure 83: East Asia Market Value (US$ Mn) by End Use, 2022-2032
Figure 84: East Asia Market Value (US$ Mn) by Country, 2022-2032
Figure 85: East Asia Market Value (US$ Mn) Analysis by Country, 2015-2032
Figure 86: East Asia Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 87: East Asia Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 88: East Asia Market Value (US$ Mn) Analysis by Product Type, 2015-2032
Figure 89: East Asia Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 90: East Asia Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 91: East Asia Market Value (US$ Mn) Analysis by Deployment Mode, 2015-2032
Figure 92: East Asia Market Value Share (%) and BPS Analysis by Deployment Mode, 2022-2032
Figure 93: East Asia Market Y-o-Y Growth (%) Projections by Deployment Mode, 2022-2032
Figure 94: East Asia Market Value (US$ Mn) Analysis by End Use, 2015-2032
Figure 95: East Asia Market Value Share (%) and BPS Analysis by End Use, 2022-2032
Figure 96: East Asia Market Y-o-Y Growth (%) Projections by End Use, 2022-2032
Figure 97: East Asia Market Attractiveness by Product Type, 2022-2032
Figure 98: East Asia Market Attractiveness by Deployment Mode, 2022-2032
Figure 99: East Asia Market Attractiveness by End Use, 2022-2032
Figure 100: East Asia Market Attractiveness by Country, 2022-2032
Figure 101: South Asia Market Value (US$ Mn) by Product Type, 2022-2032
Figure 102: South Asia Market Value (US$ Mn) by Deployment Mode, 2022-2032
Figure 103: South Asia Market Value (US$ Mn) by End Use, 2022-2032
Figure 104: South Asia Market Value (US$ Mn) by Country, 2022-2032
Figure 105: South Asia Market Value (US$ Mn) Analysis by Country, 2015-2032
Figure 106: South Asia Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 107: South Asia Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 108: South Asia Market Value (US$ Mn) Analysis by Product Type, 2015-2032
Figure 109: South Asia Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 110: South Asia Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 111: South Asia Market Value (US$ Mn) Analysis by Deployment Mode, 2015-2032
Figure 112: South Asia Market Value Share (%) and BPS Analysis by Deployment Mode, 2022-2032
Figure 113: South Asia Market Y-o-Y Growth (%) Projections by Deployment Mode, 2022-2032
Figure 114: South Asia Market Value (US$ Mn) Analysis by End Use, 2015-2032
Figure 115: South Asia Market Value Share (%) and BPS Analysis by End Use, 2022-2032
Figure 116: South Asia Market Y-o-Y Growth (%) Projections by End Use, 2022-2032
Figure 117: South Asia Market Attractiveness by Product Type, 2022-2032
Figure 118: South Asia Market Attractiveness by Deployment Mode, 2022-2032
Figure 119: South Asia Market Attractiveness by End Use, 2022-2032
Figure 120: South Asia Market Attractiveness by Country, 2022-2032
Figure 121: Oceania Market Value (US$ Mn) by Product Type, 2022-2032
Figure 122: Oceania Market Value (US$ Mn) by Deployment Mode, 2022-2032
Figure 123: Oceania Market Value (US$ Mn) by End Use, 2022-2032
Figure 124: Oceania Market Value (US$ Mn) by Country, 2022-2032
Figure 125: Oceania Market Value (US$ Mn) Analysis by Country, 2015-2032
Figure 126: Oceania Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 127: Oceania Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 128: Oceania Market Value (US$ Mn) Analysis by Product Type, 2015-2032
Figure 129: Oceania Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 130: Oceania Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 131: Oceania Market Value (US$ Mn) Analysis by Deployment Mode, 2015-2032
Figure 132: Oceania Market Value Share (%) and BPS Analysis by Deployment Mode, 2022-2032
Figure 133: Oceania Market Y-o-Y Growth (%) Projections by Deployment Mode, 2022-2032
Figure 134: Oceania Market Value (US$ Mn) Analysis by End Use, 2015-2032
Figure 135: Oceania Market Value Share (%) and BPS Analysis by End Use, 2022-2032
Figure 136: Oceania Market Y-o-Y Growth (%) Projections by End Use, 2022-2032
Figure 137: Oceania Market Attractiveness by Product Type, 2022-2032
Figure 138: Oceania Market Attractiveness by Deployment Mode, 2022-2032
Figure 139: Oceania Market Attractiveness by End Use, 2022-2032
Figure 140: Oceania Market Attractiveness by Country, 2022-2032
Figure 141: MEA Market Value (US$ Mn) by Product Type, 2022-2032
Figure 142: MEA Market Value (US$ Mn) by Deployment Mode, 2022-2032
Figure 143: MEA Market Value (US$ Mn) by End Use, 2022-2032
Figure 144: MEA Market Value (US$ Mn) by Country, 2022-2032
Figure 145: MEA Market Value (US$ Mn) Analysis by Country, 2015-2032
Figure 146: MEA Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 147: MEA Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 148: MEA Market Value (US$ Mn) Analysis by Product Type, 2015-2032
Figure 149: MEA Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 150: MEA Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 151: MEA Market Value (US$ Mn) Analysis by Deployment Mode, 2015-2032
Figure 152: MEA Market Value Share (%) and BPS Analysis by Deployment Mode, 2022-2032
Figure 153: MEA Market Y-o-Y Growth (%) Projections by Deployment Mode, 2022-2032
Figure 154: MEA Market Value (US$ Mn) Analysis by End Use, 2015-2032
Figure 155: MEA Market Value Share (%) and BPS Analysis by End Use, 2022-2032
Figure 156: MEA Market Y-o-Y Growth (%) Projections by End Use, 2022-2032
Figure 157: MEA Market Attractiveness by Product Type, 2022-2032
Figure 158: MEA Market Attractiveness by Deployment Mode, 2022-2032
Figure 159: MEA Market Attractiveness by End Use, 2022-2032
Figure 160: MEA Market Attractiveness by Country, 2022-2032
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
